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Abstract
Background and Objective An investigation of the domains Italian
patients with multiple sclerosis (MS) named as constituting their
quality of life over time.
Design We assessed, in 68 patients, QoL domains using the Sche-
dule for the Evaluation of Individual QoL: (a) before MS diagno-
sis disclosure, (b) thirty days after disclosure, and (c) after one and
(d) four years’ follow-up.
Results The life domains most frequently named by patients were
as follows: Family, Work and Finance, Hobbies, Health, Rela-
tionship with Friends and Job Eﬀectiveness. Only Health and Job
Eﬀectiveness domains varied with time. The Health domain
became a critical dimension when MS diagnosis was revealed. In
addition, patients tended to be more satisﬁed with their health
after disclosure compared to pre-diagnosis. Job Eﬀectiveness
seemed to be an important aspect until 1 year after diagnosis dis-
closure, but it tended to become less crucial over time. Family
seems to be the most important domain over time, and psycho-
logical adaptation to MS seems to be characterized by a recon-
ceptualization of aspects that revolve around oneself, such as
professional success, rather than relational or aﬀective factors.
Conclusions Evaluating the most relevant life domains for patients
and their alteration over time may provide practitioners with an
important tool in making health-related decisions, thus improving
health outcomes and QoL.
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Introduction
Monitoring individual patients’ quality of life
(QoL) is a valuable asset for care planning,
and provides important information as to the
impact of illness and care eﬀectiveness.
Several studies1–8 have investigated QoL in
people with multiple sclerosis (MS). In particu-
lar, in a recent study9 we suggested that an
early disclosure of MS diagnosis improves
QoL. Awareness of MS diagnosis, with the
provision of disease information, seems to
reduce the stressful condition of uncertainty
and enhance the process of adapting to the dis-
ease. As studies conducted in several clinical
populations suggest, after diagnosis disclosure,
patients adjust their goals and expectations10–14.
This psychological adjustment could be respon-
sible for patients’ QoL improvement despite
the awareness of a chronic illness and likely
disabilities. In literature, QoL assessment is
mainly based on a nomothetic approach15,
which assumes physical limitation as the most
important factor in determining patients’ QoL.
Standardized instruments have emerged from
this approach, and include a pre-deﬁned set of
domains, often focusing on health status [e.g.
Multiple Sclerosis QoL-54 (MSQoL-54)]. The
use of health-related questionnaires provides
valuable information, but does not reﬂect
patients’ values, or, rather, it indicates them
only in part and only implicitly, through the
impact of disability on patients’ standards.
Furthermore, the health-related questionnaires
do not investigate the capacity of the individ-
ual to achieve his/her life plans, or the process
of patient adaptation to the disease as a whole.
As pointed out in a recent study16, the generic
preference-based measures of health-related
QoL were not exhaustive in capturing the
domains that are important for people with
MS and that are impacted upon by the clinical
condition. It is important to consider that, as
the study by Rothwell and co-workers under-
lined (1997)17, patients with MS, and those
with other chronic diseases, seem to be less
concerned than their clinicians about physical
disability in their illness.
To our knowledge, no studies to date have
evaluated how patients who receive a diagnosis
of MS change their internal standards, values
and conceptualization of QoL over time. In
this study, we used longitudinal data obtained
from the Schedule for the Evaluation of Indi-
vidual QoL (SEIQoL),18 with the aim of identi-
fying which aspects of life patients with MS
consider to be essential for their well-being and
whether these aspects change over time. Using
a qualitative approach, we examined the QoL
domains that patients named in multiple inter-
views (i.e. from the start of diagnostic work-
up, namely when patients were unaware of
their diagnosis, and at three further intervals:
immediately after diagnosis disclosure, and at 1
and 4 years after). In particular, we extracted
the SEIQoL qualitative data derived from a
more extensive project on the Prognosis of MS
(Gruppo Emiliano-Romagnolo Neurologici In
Multiple Sclerosis – G.E.Ro.N.I.Mu.S9,19).
Materials and methods
In this study, we used data from a more
extensive study on the prognosis of MS
(G.E.Ro.N.I.Mu.S). Speciﬁcally, we extracted
qualitative data derived from the SEIQoL, one
of the QoL instruments administered to the
recruited patients in the G.E.Ro.N.I.Mu.S
study9,19.
Participants
Eligible participants were patients who had
shown symptoms suggestive of MS in the last
6 months or less. Exclusion criteria were as fol-
lows: (i) age under 18 years; (ii) cognitive
impairment as judged by the treating neurolo-
gist; and (iii) inability to undergo MRI to
assess MS diagnosis according to McDonald’s
2005 criteria20. Patients were recruited in 16
Neurological Units that were part of the
G.E.Ro.N.I.Mu.S. study. The study was
approved by the Ethical Committee on Human
Research at each aﬃliation of the Units
involved, and informed consent was obtained
from all participants.
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Assessment
QoL was assessed by SEIQoL – visual ana-
logue scale (SEIQoL-VAS)18. SEIQoL-VAS is
a semi-structured interview in which patients
are invited to freely nominate the ﬁve domains
they currently consider to be the most impor-
tant in their lives, followed by a rating, on a
vertical visual analogue scale (VAS, score
range: 0–10), of current satisfaction and impor-
tance of each of the chosen areas. For more
details concerning the method of administra-
tion of SEIQoL, see the related manual18,21.
Neurological disability was assessed using
the Expanded Disability Status Scale (EDSS)22.
Study procedure
The enrolment of patients has been described
in detail in previous published papers19,22.
Researchers (a psychologist, in most cases)
from each centre were instructed on how to
administer SEIQoL. An expert conducted the
training during a one-day session.
To encourage a frank and open discussion, the
clinician–researcher was not directly involved in
patient care. Speciﬁcally, researchers introduced
the interview by explaining: ‘I would like you to
help me to understand how you feel in this per-
iod. Satisfaction and happiness in life depend on
fundamental values and activities that could be
diﬀerent for each of us. In fact, what is impor-
tant for me or for a friend of yours might not be
as important for you. Moreover, we often realize
what is important, and how much, when some-
thing changes or when we think it might change.
Please list the ﬁve dimensions/aspects that you
consider to be the most important in your daily
life and that determine your QoL’. Researchers
recorded a meaningful summary of what the
patients said. At the end of this phase, the clini-
cian–researcher categorized the answers, with the
patient’s agreement, into discrete categories on
the basis of the most common life domains in lit-
erature, for example family and hobbies13,21,23,24.
As far as the Work dimension is concerned, the
researcher had to distinguish between two cate-
gories based on the speciﬁc content of the
patient’s response: one category refers to the eco-
nomic aspect (i.e. Work and Finance) and the
other regards personal fulﬁlment (i.e. Job Eﬀec-
tiveness). Once the ﬁve general categories have
been identiﬁed, patients rated, on a VAS, how sat-
isﬁed they felt regarding each area and the impor-
tance that it had for them. The interview lasted
approximately 30 min.
Patients were assessed in a private setting at
study inclusion (T0), 30 days after diagnosis dis-
closure (T30) and one (T1y) and 4 (T4y) years
after diagnosis. Diagnosis of MS was made
according to the 2005 version of McDonald’s
criteria20, and it was considered to be disclosed
after the neurologist had informed patients of
the nature of the condition and therapeutic
procedures, including possible alternatives and
possible outcomes.
Data analysis
Categorization of QoL domains
Life domains elicited from participants during
the completion of the SEIQoL-VAS were
extracted. Three researchers independently
reviewed the life domains derived from the inter-
view, and classiﬁed any domains that did not ﬁt
into the most common categories13,21,23,24. In
almost all cases, the patients’ answers had been
correctly placed into categories by the clinician–
researchers. In the few instances in which the
answers needed to be recategorized (inter-rater
agreement, as assessed by kappa coeﬃcient, was
0.94), the researchers decided on the correct cat-
egory through discussion.
Statistical analysis
We recorded the frequency (%) of each
domain across all assessments.
Cochran’s Q and McNemar statistics were
used to compare the frequency of the named
domains between the four assessments (only
domains reported by nearly 50% of the patients
were included in analyses). a-values were
corrected according to Bonferroni adjustment;
in multiple comparisons, values <0.012 were
considered as statistically signiﬁcant.
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We performed Fisher’s exact test to explore the
association between education (patients were cat-
egorized in accordance with their level of school-
ing within the Italian school system as: fewer
than 8 years of education; from 8 to 13 years of
education; more than 13 years of education) and
the frequency of named dimensions.
To explore the changes in the rating of
importance and satisfaction, independently
repeated-measure ANOVAs (T0 vs. T30 and T30
vs. T1y vs. T4y) were conducted for each of
the six most represented domains (i.e. domains
reported by nearly 50% of the patients).
In order to ascertain whether the results of
our study could be due to a selection bias, we
performed two additional post hoc analyses: (i)
by means of Fisher’s exact test, we compared
the T0 scores for each life dimension of drop-
out patients (i.e. patients that did not have
four observations, n = 36) and those that com-
pleted the study (n = 32); (ii) using McNemar
test, we compared T30 with baseline (T0)
scores for all patients who had data at these
two time points (n = 55).
Results
Sample
Sixty-eight patients completed the initial screen-
ing [49 female, mean age 33.4  6.9; mean years
of education 12.2  3.2; job: 18 employees in
the private sector, 16 industrial workers, 10
entrepreneurs, 6 artisans, 5 civil servants (e.g.
administrative workers at the city hall or in
a public hospital)], 4 freelancers, 3 teachers,
3 nurses, 2 businessmen, 1 professional athlete).
Fifty-eight patients came from the north of
Italy, while the remaining 10 came from a cen-
tral region of Italy. Of the 68 patients who com-
pleted the initial screening, 50 patients knew
that they had a clinically isolated syndrome
(CIS) disclosed by a previous centre, while 18
patients did not know their diagnosis. At the
end of the screening, 61 received a disclosure of
MS and data at T30 were fully available for 55
patients (7 patients did not fulﬁl the diagnostic
criteria and remained classiﬁed as CIS, 4
patients withdrew the informed consent after
MS diagnosis disclosure, and for 2 patients, data
at T30 were incomplete). All 55 patients had
clinically deﬁnite relapsing–remitting MS. Clini-
cal characteristics of the patients are reported in
Table 1. In the subsequent follow-up, some
patients dropped out mainly due to incomplete
interviews, patient migration to other neurologi-
cal units or missed follow-up visits (see Table 1
for the N sample). Of the 32 patients who com-
pleted the study, 8 patients changed their job
between T30 and T1y, while 3 patients changed
their job between T1y and T4y.
QoL data
Table 2 lists the life domains named by partici-
pants and, for each domain, shows the propor-
tion of patients at diﬀerent times of assessment.
Family, Work Finance, Hobbies, Health, Rela-
tionship with Friends and Job Eﬀectiveness were
the life areas that were most frequently named
by participants (nearly 50% of patients). In
Appendix A, we report a list of speciﬁc aspects
elicited from patients that actually constitute the
extracted life domain together with some exam-
ples of what participants speciﬁcally said.
For brevity, comparisons that failed to reach
statistical signiﬁcance are not reported. Two life
domains varied as a function of time: Health
(Q = 24.12; P < 0.001) and Job Eﬀectiveness
(Q = 17.01; P < 0.001). Speciﬁcally, theMcNemar
test revealed that Health was signiﬁcantly less
frequently named by patients at the start of the
screening period compared both to 30 days after
diagnosis disclosure and to the subsequent
follow-ups (T0 vs. T30, T1y and T4y ps < 0.001);
there were no diﬀerences between T30 and T1y,
T2y. Moreover, Job Eﬀectiveness was signiﬁ-
cantly less frequently named at T4y compared to
T1y, T30 and T0. To explore changes in the rating
of importance and satisfaction, independently
repeated-measure ANOVAs (T0 vs. T30 and T30
vs. T1y vs. T4y), were conducted for each of the
six most represented domains (i.e. Family, Work
Finance, Hobbies, Health, Relationship with
Friends and Job Eﬀectiveness). The only signiﬁ-
cant, or near-signiﬁcant, comparisons were the
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following (see Fig. 1): Job Eﬀectiveness was
rated less important at T4y compared to both
T30 and T1y (87.31  17.24 vs. 87.38  18.04
vs. 39.15  45.75; F(1,24) = 10.15, P = 0.003,
g2p = 0.46; T30 vs. T4y P = 0.012, T1y vs. T4y
P = 0.020). Health satisfaction tended to be
higher immediately after diagnosis disclosure
(46.32  28.46 vs. 56.84  24.27, F(1,24) = 3.49,
P = 0.074, g2p = 0.13). The importance and satis-
faction did not diﬀer as a function of time in
other life dimensions.
A repeated-measure ANOVA suggested that
disability (i.e. EDSS score) did not vary signiﬁ-
cantly as a function of time. Moreover, we
Table 1 Clinical, MRI characteristics and therapies
Diagnosis screening
start point
(T0) n = 68
30 days after
diagnosis disclosure
(T30) n = 55
1 year follow-up
(T1y) n = 50
4 years of follow-up
(T4y) n = 32
EDSS
Nr. pts
0.0–2.5 61 54 47 28
3.0–6.0 7 1 3 4
>6.0 0 0 0
MRI Lesions
Median (IQR)
T2 lesions 10.5 (4–21.5) – – –
Gd–enhancing lesions 0 (0–1.5)
CSF
Nr. pts
45 – – –
Treatment
Nr. pts
IV Steroid 54 – 14 10
Immunomodulatory 2 24 23
Other 2 2 2
Table 2 QoL Domains named by participants listed on the basis of the frequency (%)
Diagnosis screening
start point
(T0) n = 68
30 days after
diagnosis disclosure
(T30) n = 55
1 year follow-up
(T1y) n = 50
4 years follow-up
(T4y) n = 32
Family (94.1) Family (98.1) Family (97.9) Family (97.0)
Work finance (64.7) Health (75.9) Health (79.2) Health (82.5)
Hobbies (57.4) Work finance (72.2) Work finance (68.8) Work finance (75.8)
Health (55.9) Hobbies (66.7) Hobbies (62.5) Relationship with
friend (69.7)
Relationship with friend (55.9) Relationship with friend (63.0) Relationship with friend (58.3) Hobbies (66.7)
Job effectiveness (48.5) Job effectiveness (50.0) Mental health (45.8) Mental health (33.3)
Mental health (44.1) Mental health (42.6) Job effectiveness (33.3) Social life/activities (27.3)
Social life/activities (25.0) Social life/activities (27.8) Social life/activities (33.3) Partner (27.3)
Partner (25.0) Partner (22.2) Partner (27.1) Job effectiveness (24.8)
Religion (13.2) Religion (11.1) Religion (12.5) Religion (12.1)
Sex (5.9) Independence (7.4) Sex (4.2) Sex (3.0)
Life environment (4.4) Life environment (5.6) Life environment (4.2) Clinical staff
relationship (3.0)
Independence (2.9) Sex (3.7) Independence (2.1) Independence ()
Clinical staff relationship () Clinical staff relationship (3.7) Child care (2.1) Child care ()
Child care () Child care (1.9) Clinical staff relationship () Life environment ()
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did not ﬁnd any statistically signiﬁcant diﬀer-
ence in the distribution of frequency of the
named dimensions by years of education.
Finally, we found that, at T0, dropout
patients less frequently considered Health (Fish-
er’s Exact Test P = 0.006) as an important life
dimension compared to those with complete
follow-up. As this gives a potential for selection
bias, we compared T30 with baseline (T0) scores
for all patients who had data from these two
time points (55 of the 68 patients). As in the full
model including patients with complete follow-
up (n = 32), we found that Health was named
more frequently 30 days after diagnosis dis-
closure (McNemar test P < 0.001). We also per-
formed a similar subanalysis for Job Eﬀective-
ness at time point T0 vs. T30, including all 55
patients with data from these two time points.
Again, we found a similar result as in the full
model with no statistically signiﬁcant diﬀerences
in the frequency with which patients nominated
Job Eﬀectiveness at these two time points.
Discussion
In the present study, we explored the self-named
QoL domains in patients with MS from the onset
of symptoms that were suggestive of MS and at
three further intervals: immediately after MS
diagnosis disclosure and at 1 and 4 years post-
diagnosis. The most frequent life domains named
by patients were as follows: Family, Work and
Finance, Hobbies, Health, Relationship with
Friends and Job Eﬀectiveness. The results are
consistent with research conducted in patients
with MS16, in patients with other diseases and in
healthy adults13,21,24. It is important to note that
the labelled domains derived from more speciﬁc
aspects that could diﬀer between patients. For
example, for Family, participants could refer to:
‘family support’, ‘creating my own family’, ‘par-
ents’, etc. (see Appendix A formore detailed data).
The ﬁndings also showed that Health and
Job Eﬀectiveness changed over time, that is the
number of patients reporting these two aspects
changed, whereas the majority of named life
domains were stable. The Health domain
became a critical dimension when patients were
made aware of MS diagnosis. In addition,
patients tended to be more satisﬁed with their
health after diagnosis disclosure compared to
the pre-diagnosis period. This is in line with
data concerning the importance of an early dis-
closure of MS diagnosis for the patients’ well-
being and QoL4,6,9,24,25. Providing patients with
information and clariﬁcation about their symp-
toms reduces uncertainty. It increases the
patients’ feeling of control and it decreases
their level of anxiety and stress, thus improving
their overall health satisfaction regardless of
any improvement in the symptomatology9.
(a)
(b)
Figure 1 Rating of Importance and Satisfaction attributed
to the most recurrent life domains named by participants
30 days after diagnosis disclosure (T30).
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As in previous research on chronic
illnesses24, we found that patients with MS
tended to be less satisﬁed with the Health
domain compared to the other domains (see
Fig. 1), mainly Family, which seems to be the
central life domain for MS patients over time.
Job Eﬀectiveness seems to be an important
aspect of patients’ life until 1 year after diagno-
sis disclosure, but it tends to become a less
crucial domain over time. Speciﬁcally, fewer
patients indicated Job Eﬀectiveness 4 years after
diagnosis disclosure, and in those patients who
continued to nominate Job Eﬀectiveness, it
became less important than originally perceived.
We are cognizant of a number of limitations
of the present study. The results have to be inter-
preted with caution because of the small sample
size and the relatively high dropout rate. The
sensitivity analysis showed that the patients with
complete follow-up, more often than those with
missing data, evaluated Health as more impor-
tant at baseline. However, when including all 55
patients (81% of the total study population)
with data on both baseline and 30 days after
diagnosis disclosure, we found similar results as
when we included patients with complete follow-
up only. These results argue against our ﬁndings
being entirely caused by selection bias due to the
substantial dropout rate. Nevertheless, the num-
ber of patients involved is rather limited, and
therefore, the study is underpowered to detect
smaller diﬀerences.
Another limitation is that the low EDSS
scores preclude any evaluation of the inﬂuence
of disability on the estimated associations.
Moreover, even the years of education do not
seem to shape the dimension that patients indi-
cated as the most important in their lives. The
rather homogeneous cultural background of our
sample (primarily people from the north of
Italy) and the prevalence of women prevent us
from determining any potential eﬀect of gender
and the region of origin.
In summary, these ﬁndings, pertaining to
Italian patients with low disability and quite
stable disease, suggest that psychological adap-
tation to chronic diseases with an unpredictable
clinical course, such as MS, is mainly character-
ized by a reconceptualization of domains that
revolve around oneself, such as professional
success, rather than relational domains. More-
over, the changes in signiﬁcance of QoL
domains, although limited, seem to become
manifest a few years after diagnosis disclosure.
It is important to note that, in our sample,
individuals’ neurological disability did not sig-
niﬁcantly change over time (as shown by the
EDSS score) which may be the reason why no
other change was observed in named life
domains or in the importance and satisfaction
rating between the assessments.
It is increasingly evident that knowing all rele-
vant domains of patients’ health is a fundamental
prerequisite for clinical practice26. Matching
medical approaches to patients’ priorities, that is,
tailoring intervention strategies as much as possi-
ble, allows for the most appropriate health-
related decisions (e.g. drug choice, risk tolerance,
treatment adherence, etc.) and maximizes QoL
and health outcomes of patients27–29. This is
especially relevant in the management of chronic
diseases such as MS. Speciﬁcally, this study high-
lights the possibility of basing treatment choice
in MS patients on two main domains: personal
relationships (i.e. family and friends) and self-
eﬃcacy (i.e. work and hobbies). Analysing the
way in which these dimensions aﬀect the QoL of
MS patients could help health professionals to
personalize health management, and thus maxi-
mize patients’ adherence and the eﬃcacy of all
health-related decisions, in order to achieve a bet-
ter outcome. According to these ﬁndings, during
the clinical examination, practitioners should
investigate patients’ goals, standards, expecta-
tions, concerns and changes in these aspects over
time. Simple questions may be used, for example
adaptations of those used in the SEIQoL inter-
view. It is important to note that valuable infor-
mation can be obtained without signiﬁcantly
aﬀecting the duration of the appointment.
In future studies, it would be interesting to
verify whether using these strategies enables
practitioners to improve their decision-making
regarding patient’s care and, alongside this,
whether patients’ health-care satisfaction can be
improved. As patients naming a QoL dimension
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by reference to speciﬁc aspects may be diﬀerent
for each of them (i.e. family support vs. taking
care of family), it would also be of interest to
investigate, in future studies, what speciﬁcally
changes within the stable life area over time. In
fact, hypothetically, if a patient answered: ‘The
relationship with my family: my family is extre-
mely important for me’ at the ﬁrst interview and
‘Having family support and understanding’
afterwards, these aspects were both categorized
as Family even though they could have diﬀerent
meanings for the patient.
In conclusion, giving attention to person-
centred aspects other then the clinical symp-
toms of the disease, such as the domains that
patients identify as the most relevant in their
life and their alteration over time, may provide
practitioners with an important tool in making
health-related decisions and possibly altering
health-care providers’ decisional habits. More-
over, the patient-centred approach contributes
to reinforce the therapeutic alliance that is a
fundamental prerequisite for medical care
adherence and the eﬃcacy of treatments.
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Appendix A The Life dimensions extracted from the SEIQoL, and the specific aspects that
constitute these dimensions
Life dimension
Specific aspect
(what actually constitutes
the life dimensions) Example (what patient specifically said)
Family Creating my own family ‘The chance to create my own family and
have kids’
Family ‘Spending time with my family’
Family Relationship ‘The relationship with my family: my family is
extremely important for me’
Family Support ‘Having family support and understanding’
Family Life at Home ‘My life at home with my family’
Relationship with Parents ‘My parents and the relationship with them’
Relatives ‘The relationship with my relatives, my whole
family, my sisters, my parents, my grandparents’
Relatives’ Health ‘The health of my whole family, I am worried
about their health and well-being’
Sharing with Family ‘Sharing with my family and spending
time together’
Sister ‘My sister and my nephews and nieces’
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Appendix A Continued
Life dimension
Specific aspect
(what actually constitutes
the life dimensions) Example (what patient specifically said)
Work/Finance Job as Economic
Independence
‘My job gives me economic self-sufficiency,
working improves quality of life’; ‘My salary
and my financial independence’
Economic Status ‘Economic status’
Job as financial security ‘My job means financial security’
Job to Earn
Money/Money/Salary
‘My job as the possibility to earn money’; ‘To
have money’; ‘To have a salary’
Hobbies Animals ‘Companionship with my cats’
Biking ‘Biking’
Cars/Motorbike ‘Driving cars especially sports cars’
Cinema/Movies ‘Going to movies’
Cooking ‘Cooking’
Dancing ‘Dancing’
Embroidering ‘Having time and being able to embroider’
Free Time ‘Having free time for my self’
Gardening ‘I am a gardening enthusiast’
Going Out ‘Going out’
Having Fun ‘Having fun’
Hobby ‘My favorite hobbies’
Holidays/Travelling ‘Going on holiday’
Home Care ‘Taking care of my home’
Massage ‘Receiving massage and learning shiatsu
massage’
Music ‘Listening to music whenever I can’
Sport/Physical Activity ‘Doing physical activities to improve my
physical appearance’; ‘Doing sport activities’
Culture/Arts/Poetry
and Theatre
‘Culture. Participating in cultural events’; ‘Arts
make me feel happy’; ‘Reading poetry and
going to see performances at the theatre’
Reading ‘Reading books’
Swimming ‘Swimming’
Television ‘Watching television on my couch’
Volunteering ‘Spending my free time in voluntary work’
Health Desire to stay healthy ‘I would like to stay healthy to keep on doing
what I have to do’
Disease ‘The symptoms bother me’
Disease Progression ‘Hope that the disease does not progress’
Health ‘My health’
Health and Medical Treatment ‘I would like to reach a better health status
with some medical treatments’
Health Information ‘Being informed about my health
(certainty vs. uncertainty)’
Physical Health ‘Personal physical health’
Physical Well-being ‘My physical well-being and the quality of life’
Resolve Health Issues ‘I would like to resolve my health issues
and be well’
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Appendix A Continued
Life dimension
Specific aspect
(what actually constitutes
the life dimensions) Example (what patient specifically said)
Relationship with friends Enjoying Friends’ Company ‘Spending time with friends and enjoying
their company’
Friends ‘Having close friends’
Relationship with
Friends and Mutual Respect
‘The relationship with my best friends and the
respect for each other’
Having a lot of Acquaintances ‘Having a lot of acquaintances and friends’
Having Friends
different from myself
‘Socializing with people and friends different
from myself’
Friends’ Support ‘The presence of friends and their support’
Job as Social Relationships ‘My job especially because it is the main
opportunity to socialize and have friends’
Job effectiveness Ambition ‘Job ambition and personal realization’
Career ‘Reaching professional goals in order to get
a career advancement’
Feeling Accepted by
Colleagues
‘The work enviroment, my satisfaction and the
feeling of being accepted by colleagues’
Job and Self-Esteem ‘My self esteem and my quality of life is
affected also by my role at work’
Job as a passion ‘My job is my passion’
Job as Self-Fulfillment ‘My job makes me feel satisfied’
Job effectiveness ‘My job makes me feel important and it
distracts me from other problems’
Professional Acknowledgment ‘Having good professional abilities and being
acknowledged for that’
Professional Satisfaction ‘Being satisfied at work’
Success at work ‘Being successful at work’
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